Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$314K Hold
13,050
0.13% 89
2026
Q1
$366K Buy
13,050
+12,500
+2,273% +$333K 0.18% 74
2025
Q4
$13.7K Buy
+550
New +$13.9K 0.01% 238
2025
Q3
Sell
-650
Closed -$15.8K 269
2025
Q2
$15.8K Sell
650
-7,460
-92% -$174K 0.01% 242
2025
Q1
$206K Buy
8,110
+7,610
+1,522% +$199K 0.13% 97
2024
Q4
$13.3K Hold
500
0.01% 230
2024
Q3
$14.5K Sell
500
-396
-44% -$11.6K 0.01% 227
2024
Q2
$25.1K Buy
+896
New +$24.7K 0.02% 202
2023
Q3
Sell
-6,385
Closed -$234K 109
2023
Q2
$234K Buy
+6,385
New +$249K 0.2% 101

Other funds holding PFE

Olistico Wealth's PFE Position: Q2 2026 in Review

Olistico Wealth held its Pfizer (PFE) position steady in Q2 2026 at 13,050 shares worth $314K. The position accounts for 0.13% of the portfolio, ranked #89.

Olistico Wealth first reported a position in PFE in Q2 2023 and has held it in 9 quarters since. The position peaked at $366K in Q1 2026. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Olistico Wealth held 13,050 shares of Pfizer worth $314K as of Q2 2026.
  • Olistico Wealth left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.13% of Olistico Wealth's portfolio in Q2 2026, its #89 holding.
  • Olistico Wealth first reported a position in Pfizer in Q2 2023 and has held it in 9 quarters since.
  • Olistico Wealth's Pfizer position peaked at $366K in Q1 2026.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Olistico Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.